| 64.11 Delayed Data As of Aug 19 |  +0.97 / +1.54%Today’s Change | 60.32 Today|||52-Week Range 79.61 | +2.49% Year-to-Date |
| Previous close | 63.14 |
| Today’s open | 63.69 |
| Day’s range | 63.69 - 64.42 |
| Volume | 6,163,388 |
| Average volume (3 months) | 6,474,199 |
| Market cap | $80.1B |
| Earnings growth (last year) | +18.72% |
| Earnings growth (this year) | +4.98% |
| Earnings growth (next 5 years) | +3.50% |
| Revenue growth (last year) | -15.00% |
| P/E ratio | 13.8 |
| Price/Sales | 3.68 |
| Price/Book | 3.79 |
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | +4.04 | +1.74% |
| ILMNIllumina Inc | +2.48 | +0.87% |
| AMGNAmgen | +1.98 | +0.97% |
| EXASExact Sciences Corp | -1.66 | -1.39% |
| Next reporting date | October 29, 2019 |
| EPS forecast (this quarter) | $1.75 |
| Annual revenue (last year) | $22.2B |
| Annual profit (last year) | $5.5B |
| Net profit margin | 24.56% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Daniel O'Day |
CFO, Chief Accounting Officer & Executive VP Robin L. Washington |
Corporate headquarters Foster City, California |
